A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/426 (2006.01) A61K 38/55 (2006.01) A61P 1/16 (2006.01)
Patent
CA 2517831
The present invention is directed to a method for inducing UGT1A1 isoform expression for treatment of a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate comprising the step of administering to a subject an effective amount of ritonavir. In particular, the present invention is directed to a method of treating unconjugated hyperbilirubinemia by UGT1A1 induction comprising the step of administering to a subject an effective amount of ritonavir.
La présente invention concerne une méthode visant à induire l'expression de l'isoforme UGT1A1 pour le traitement d'une maladie, d'un trouble ou d'un effet indésirable généré par une concentration sérique élevée d'un substrat UGT1A1, laquelle méthode consiste à administrer à un sujet une quantité efficace de ritonavir. Cette invention concerne en particulier une méthode de traitement d'une hyperbilirubinémie indirecte par induction de UGT1A1, laquelle méthode consiste à administrer à un sujet une quantité efficace de ritonavir.
Bertz Richard J.
Kempf Dale J.
Waring Jeffrey F.
Abbott Laboratories
Torys Llp
LandOfFree
Use of ritonavir for the treatment of unconjugated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ritonavir for the treatment of unconjugated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ritonavir for the treatment of unconjugated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1536903